Matthew K Fust Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

Matthew K Fust is of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 20,205 shares of RARE, which is worth approximately $830,425. The most recent transaction as insider was on Jun 18, 2024, when has been sold 5,345 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.2K

35.97% 3M change

25.32% 12M change

Total Value Held $830,425

Matthew K Fust Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 18 2024	BUY Grant, award, or other acquisition	-	5,345 Added 20.92%	20,205 Common Stock
Mar 07 2024	SELL Open market or private sale	$620,359 $50.87 p/Share	12,195 Reduced 45.07%	14,860 Common Stock
Jun 07 2023	SELL Sale (or disposition) back to the issuer	$171,006 $51.82 p/Share	3,300 Reduced 10.87%	27,055 Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	-	3,860 Added 11.28%	30,355 Common Stock
Jun 24 2022	BUY Grant, award, or other acquisition	-	3,300 Added 11.08%	26,495 Common Stock
Mar 04 2022	BUY Exercise of conversion of derivative security	$302,775 $40.37 p/Share	7,500 Added 24.43%	23,195 Common Stock
Jun 24 2021	BUY Grant, award, or other acquisition	-	2,145 Added 12.02%	15,695 Common Stock

Also insider at

CRNX

Crinetics Pharmaceuticals, Inc. Healthcare

ATRA

Atara Biotherapeutics, Inc. Healthcare

NMRA

Neumora Therapeutics, Inc.

MKF

Matthew K Fust

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Value

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Track Activities on RARE

Account